Mai Hashimoto

434 total citations
25 papers, 331 citations indexed

About

Mai Hashimoto is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mai Hashimoto has authored 25 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Mai Hashimoto's work include HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Genetic factors in colorectal cancer (3 papers). Mai Hashimoto is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Genetic factors in colorectal cancer (3 papers). Mai Hashimoto collaborates with scholars based in Japan, United States and Malaysia. Mai Hashimoto's co-authors include Kenji Monde, Nobuaki Miura, Tamotsu Inabe, Tohru Taniguchi, Md. Masudur Rahman, Hachiro Yasuda, Akira Mizuno, Kazunori Takashima, Masaki Otagiri and Tamotsu Sugai and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Mai Hashimoto

25 papers receiving 325 citations

Peers

Mai Hashimoto
Meher K. Prakash Switzerland
N. Tajima Japan
Robert L. Wells United States
Sylvain Cecchini United States
Mai Hashimoto
Citations per year, relative to Mai Hashimoto Mai Hashimoto (= 1×) peers Ken Akamatsu

Countries citing papers authored by Mai Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Mai Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai Hashimoto more than expected).

Fields of papers citing papers by Mai Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai Hashimoto. The network helps show where Mai Hashimoto may publish in the future.

Co-authorship network of co-authors of Mai Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mai Hashimoto. A scholar is included among the top collaborators of Mai Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai Hashimoto. Mai Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Mai, et al.. (2024). Therapeutic Effect of Natural Products and Dietary Supplements on Aflatoxin-Induced Nephropathy. International Journal of Molecular Sciences. 25(5). 2849–2849. 10 indexed citations
2.
Hashimoto, Mai, et al.. (2024). Self-Propelled Tubular Micromotors Powered by Hydrogen Bubbles under Mild Conditions: A Major Step toward Biological Applications with Live Cells. ACS Applied Bio Materials. 7(11). 7740–7747. 4 indexed citations
3.
Yanagawa, Naoki, Mai Hashimoto, Mitsumasa Osakabe, et al.. (2022). Correlation of tumor microenvironment-related markers with clinical outcomes in patients with squamous cell carcinoma of the lung. Translational Lung Cancer Research. 11(6). 975–990. 8 indexed citations
4.
Hashimoto, Mai, Noriyuki Uesugi, Kazuhiro Ito, et al.. (2022). Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(4). 793–805. 7 indexed citations
5.
Hashimoto, Mai, Hitoshi Maeda, Kentaro Oniki, et al.. (2022). New Insight Concerning Therapeutic Drug Monitoring—The Importance of the Concept of Psychonephrology—. Biological and Pharmaceutical Bulletin. 45(7). 834–842. 3 indexed citations
6.
Hashimoto, Mai, Noriyuki Uesugi, Mitsumasa Osakabe, et al.. (2021). Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. Frontiers in Oncology. 11. 690816–690816. 15 indexed citations
7.
Sugai, Tamotsu, Noriyuki Yamada, Mitsumasa Osakabe, et al.. (2021). Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer. Histopathology. 79(4). 584–598. 19 indexed citations
8.
Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Hiroki Kumamoto, et al.. (2020). Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV. Journal of Hepatology. 74(5). 1075–1086. 21 indexed citations
9.
Hashimoto, Mai, Victor Tuan Giam Chuang, Yu Ishima, et al.. (2020). A Safety Evaluation Study in Mice Revealed that Albumin Dimer is Safe for Medical and Pharmaceutical Applications. 3(2). 87–91. 2 indexed citations
10.
Nishi, Koji, et al.. (2020). Effects of Oxidation of Human Serum Albumin on the Binding of Aripiprazole. Biological and Pharmaceutical Bulletin. 43(6). 1023–1026. 7 indexed citations
11.
Taguchi, Kazuaki, Victor Tuan Giam Chuang, Mai Hashimoto, et al.. (2020). Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique. Chemical and Pharmaceutical Bulletin. 68(8). 766–772. 3 indexed citations
12.
Nishi, Koji, Yoshihiro Kobashigawa, Hiroshi Morioka, et al.. (2019). Interaction of Aripiprazole With Human α1-Acid Glycoprotein. Journal of Pharmaceutical Sciences. 108(12). 3911–3916. 6 indexed citations
13.
Nishi, Koji, Shuhei Imoto, Mai Hashimoto, et al.. (2018). Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin. Journal of Pharmaceutical Sciences. 108(5). 1890–1895. 6 indexed citations
14.
Hashimoto, Mai, Kazuaki Taguchi, Satoru Kohgo, et al.. (2018). Pharmacokinetic properties of a novel inosine analog, 4′-cyano-2′-deoxyinosine, after oral administration in rats. PLoS ONE. 13(6). e0198636–e0198636. 2 indexed citations
16.
Hashimoto, Mai, Kazuaki Taguchi, Hiroshi Watanabe, et al.. (2015). Pharmacokinetic Properties of Single and Repeated Injection of Liposomal Platelet Substitute in a Rat Model of Red Blood Cell Transfusion-Induced Dilutional Thrombocytopenia. Journal of Pharmaceutical Sciences. 104(11). 3968–3976. 1 indexed citations
17.
Monde, Kenji, et al.. (2009). Super water- and highly oil-repellent films made of fluorinated poly(alkylpyrroles). Colloids and Surfaces A Physicochemical and Engineering Aspects. 354(1-3). 234–239. 32 indexed citations
18.
Yasuda, Hachiro, Mai Hashimoto, Md. Masudur Rahman, Kazunori Takashima, & Akira Mizuno. (2008). States of Biological Components in Bacteria and Bacteriophages during Inactivation by Atmospheric Dielectric Barrier Discharges. Plasma Processes and Polymers. 5(6). 615–621. 51 indexed citations
19.
Hashimoto, Mai, et al.. (2007). Fundamental study on quasi-real-time detection of airborne bio-particles using discharge plasma. Thin Solid Films. 516(19). 6699–6703. 2 indexed citations
20.
Nakamura, Tomoki, Naoya Imae, Izumi Nakai, et al.. (1999). Antarctic micrometeorites collected at the Dome Fuji Station. Institutional Repository National Institute of Polar Research (National Institute of Polar Research (Japan)). 12. 183–198. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026